LILLY ENDOWMENT INC
Long book
$84.52B
Q1 2026
Positions
1
Top-10 weight
100%
concentration
Last quarter
+32.2%
SPY +14.8%
Turnover
0%
of book per quarter
Strategy in plain words
auto-generated from filingsLILLY ENDOWMENT INC is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $84.52B US long book across 1 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: ELI LILLY & CO.
Over the last 9 quarters its long book ran on average 2.3pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+16.6%
Q2 2024
-2.0%
Q3 2024
-12.7%
Q4 2024
+7.2%
Q1 2025
-5.4%
Q2 2025
-1.9%
Q3 2025
+41.1%
Q4 2025
-14.3%
Q1 2026
+32.2%
Sector allocation
Healthcare 100%
Long book by quarter
What does LILLY own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| LLY ELI LILLY & CO | Healthcare | 91.9M | $84.52B | 100.0% | -0.3% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | Apr 20, 2026 | 1 | $84.52B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Jan 23, 2026 | 1 | $99.08B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Oct 31, 2025 | 1 | $72.86B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Jul 10, 2025 | 1 | $74.85B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | Apr 16, 2025 | 1 | $79.30B | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Jan 27, 2025 | 1 | $74.80B | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Oct 3, 2024 | 1 | $85.84B | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Jul 16, 2024 | 1 | $88.15B | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | Apr 16, 2024 | 1 | $76.94B | canonical | SEC ↗ |